Tech Company Financing Transactions
Solace Therapeutics Funding Round
Private investors invested in a $13 million capital raise for Solace Therapeutics. This venture round was announced on 9/8/2016.
Transaction Overview
Company Name
Announced On
9/8/2016
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
135 Newbury St.
Framingham, MA 01701
USA
Framingham, MA 01701
USA
Phone
Website
Email Address
Overview
Solace Therapeutics is developing a non-surgical device specifically for the treatment of Stress Urinary Incontinence (SUI).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Gruber
VP - Marketing
Nicole Shugrue
VP - R & D
Albert Chin
VP - Regulatory Affairs
Scott Blood
VP - Regulatory Affairs
Joshua Freeman
Browse more venture capital transactions:
Prev: 9/8/2016: iStaging venture capital transaction
Next: 9/8/2016: Cielo24 venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs